Growth hormone treatment of short children with chronic renal failure before and after renal transplantation: Rationale and recent results

Nephrology Dialysis Transplantation

Volumn 11, Issue 9, 1996, Pages 1747-1750

  Mehls, O ^a   Wuhl E ^a   Haffner, D ^a   Schaefer, F ^a   Tonshoff B ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE;

ARTICLE; CHILD; CHRONIC KIDNEY FAILURE; HORMONAL THERAPY; HUMAN; IMMUNOPATHOLOGY; KIDNEY TRANSPLANTATION; METABOLIC DISORDER; PRIORITY JOURNAL; SHORT STATURE;

EID: 0029798626     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.9.1747     Document Type: Article

References (39)

1. Koch VH, Lippe BM, Nelson PA et al. Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure. J Pediatr 1989; 115: 365-371
2. Tönshoff B, Mehls O, Heinrich U et al. Growth stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 1990; 116: 561-566
3. Tönshoff B, Haffner D, Mehls O et al. Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience. Kidney Int 1993; 44: 199-207
4. Haffner D, Schaefer F, Girard J et al. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest 1994; 93: 1163-1171
5. Schaefer F, Baumann G, Haffner D et al. Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. J Clin Endocrinol Metab 1996; 81: 22-31
6. Schaefer F, Hamill G, Stanhope R et al. Pulsatile growth hormone secretion in peripubertal patients with chronic renal failure. J Pediatr 1991; 119: 568-577
7. Tönshoff B, Veldhuis JD, Heinrich U et al. Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with chronic renal failure. Pediatr Res 1995; 37: 86-93
8. Postel-Vinay MC, Tar A, Crosnier H et al. Plasma growth hormone binding protein is low in uraemic children. Pediatr Nephrol 1991; 5: 545-547
9. Tönshoff B, Edén S, Weiser E et al. Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 1994; 45: 1085-1092
10. Powell D, Rosenfeld R, Sperry J et al. Serum concentrations of insulin-like growth factor (IGF)-1, IGF-2 and unsaturated somatomedin carrier proteins in children with chronic renal failure. Am J Kidney Dis 1987; 10: 287-292
11. Blum WF, Ranke MB, Kietzmann K, Tönshoff B, Mehls O. Growth hormone resistance and inhibition of somatomedin activity by excess of insulin-like growth factor binding protein in uremia. Pediatr Nephrol 1991; 5: 539-544
12. Drop SLS, Brinkman A, Kortleve DJ, Groffen CAH, Schuller A, Zwarthoff EC. The evolution of the insulin-like growth factor binding protein familiy. In: Spencer EM, ed. Mondern Concepts of Insulin-like Growth Factors. Elsevier, New York. 1991; 311-328
13. Tönshoff B, Blum WF, Wingen AM, Mehls O. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2 and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate. J Endocrinol Metab 1995; 80: 2684-2691
14. Tönshoff B, Powell DR, Zhao D et al. Decreased hepatic insulin-like growth factor (IGF)-1 and increased IGF binding protein (IGFBP)-1 and -2 gene expression in experimental uremia. J Am Soc Nephrol 1995; 6: 1032
15. Blum WF. Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatr Scand 1991; 379 [Suppl]: 24-31
16. Veldhuis JD, Lizarralde G, Iranmanesh. Divergent effects of short term glucocorticoid excess on the gonadotropic and somatotropic axes in normal men. J Clin Endocrinol Metab 1992; 74: 96-102
17. Wehrenberg WB, Janowski BA, Piering AW et al Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion. Endocrinology 1990; 126: 3200-3203
18. Schaefer F, Veldhuis JD, Stanhope R et al. Alterations in growth hormone secretion and clearance in peripubertal boys with chronic renal failure and after renal transplantation. J Clin Endocrinol Metab 1994; 78: 1298-1306
19. Gabrielsson BG, Carmignac DF, Flavell DM, Robinson ICAF. Steroid regulation of growth hormone (GH) receptor and GH binding protein messenger ribonucleic acids in the rat. Endocrinology 1995; 133: 2445-2452
20. Tönshoff B and Mehls O. Use of rhGH posttransplantation in children. In: Tejani AH, Fine RN, eds. Pediatric Renal Transplantation. Wiley-Liss Inc, New York. 1994; 441-459
21. Bang P, Degerblad M, Thoren M et al. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. Acta Endocrinol 1993; 128: 397-404
22. Luo J, Murphy LJ. Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 1989; 125: 165-171
23. Unterman TG and Phillips LS. Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endoerinol Metab 1985; 61: 618-626
24. Silbermann M and Maor G. Mechanisms of glucocorticoid-induced growth retardation: impairment of cartilage mineralization. Acta Anatomica 1978; 101: 140-149
25. Jux C, Leiber K, Hügel U et al. Dexamethasone inhibits GH stimulated and IGF-I mediated proliferation by reduction of paracrine IGF-I secretion and somatotropic receptor downregulation in cultured growth plate chondrocytes. (Abstract). Tenth International Congress of Endocrinology, San Francisco, 1996; (in press)
26. Fine RN, Kohaut EC, Brown D et al. Growth after recombinant human growth hormone treatment in children with chronic renal failure: Report of a multicenter randomized double-blind placebo-controlled study. J Pediatr 1994; 124: 374-382
27. Mehls O, Broyer M, on behalf of the European/Australian Study Group: Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. Acta Paediatr 1994; 399 [Suppl]: 81-87
28. Haffner D, Wühl E, Tönshoff B et al. Growth hormone (GH) treatment in short children with chronic renal failure (CRF): A 5 year follow-up (Abstract) .Pediatr Nephrol 1994; 8: C40
29. Fine RN, Kohaut E, Brown D, Kuntze J, Attie KM. Long-term treatment of growth retarded children with chronic renal insufficiency. with recombinant human growth hormone. Kidney Int 1996; 49: 781-785
30. Tönshoff B, Tönshoff C, Mehls O et al. Growth hormone treatment in children with preterminal chronic renal failure: No adverse effect on glomerular filtration rate. Eur J Pediatr 1992; 151: 601-607
31. Wühl E, Haffner D, Nissel R, Schaefer F, Mehls O, and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatr Nephrol 1996; (in press)
32. Wühl E, Haffner D, Tönshoff B, Mehls O, and the German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Predictors of growth response to rhGH in short children before and after renal transplantation. Kidney Int 1993; 44 [Suppl]: 76-82
33. Fine RN, Yadin O, Moulten L, et al. Extended recombinant human growth hormone treatment after renal transplantation in children. J Am Soc Nephrol 1992; 2 [Suppl]: S274-S283
34. Broyer M, on behalf of the study group. A multicenter, open, randomized, controlled study evaluating the effect of growth hormone therapy in short children after renal transplantation (Abstract). Pediatr Nephrol 1995; 9: C49
35. Hokken-Koelega ACS, Stijnen T, De Ridder MAJ et al. Growth hormone treatment in growth-retarded adolescents after renal transplantation. Lancet 1994; 343: 1313-1317
36. Haffner D, Zacharewicz S, Mehls O, Heinrich U, Ritz E. The acute effect of growth hormone on GFR is obliterated in chronic renal failure. Clin Nephrol 1989; 32: 266-269
37. Ingulli E, Tejani AH. Steroid withdrawal after renal transplantation. In: Tejani AH, Fine RN, eds. Pediatric Renal Transplantation. Wiley-Liss, New York; 1994: 221-238
38. Malozowski S, Tanner LA, Wysowski D, Fleming GA. Growth hormone, insulin-like growth factor I, and benign intracranial hypertension. N Engl J Med 1993; 329: 665-666
39. Watkins SL. Is severe renal osteodystrophy a contraindication for rhGH treatment? Pediatr Nephrol 1996; 10: 351-354